Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BF-200 ALA vs MAL in NDL-PDT for Actinic Keratosis
NCT02464709Phase 4Completed
- Sponsor
- Päijät-Häme Wellbeing Services County
- Start
- Jun 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aminolevulinic acid 10% gel in actinic keratosis (AK), sponsored by Päijät-Häme Wellbeing Services County. Started Jun 2015; status: completed.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02464709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02464709.